Red X iconGreen tick iconYellow tick icon

Contact Details

Email
william.leung@otago.ac.nz
Position
Senior Lecturer
Department
Department of Public Health (Wellington)
Qualifications
MSc (Op Res), MSc (Comp Sci), MSc (Health Econ)
Research summary
Health Economics

Research

William is the health economist at the Faculty of Medicine – Wellington. He has a been a named health economist co-investigator on over $20m of contestable New Zealand research funding.

Current and past projects have included meta-analyses of the effect of calcium intake on:

and within-trial and decision-analytic cost-effectiveness analyses (as well as cost/burden studies) in areas such as:

He is leading the economic component of the US Centers for Disease Control and Prevention-funded Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) multi-agency project (Professor Michael Baker), and is part of several international health economics collaborations eg on rheumatic fever, skin cancer, neuro-endocrine tumours, and multiple sclerosis.

Within New Zealand, he is involved with external consultancy work for government agencies. For example, The Royal Society of New Zealand's 2017 evidence update of antimicrobial resistance, and peer reviewing, for the Social Policy Evaluation and Research Unit (Families Commission), PwC's economic evaluation of the Prime Minister's $64m Youth Mental Health Project.

Before training as a health economist at the University of York, he was an operational research analyst (working with Professor Val Belton, Dr. Mark Elder and others) in the British National Health Service applying discrete-event simulation and other tools to modelling cancer treatment pathways.

Publications

Noble, J. H., Bean, O., Perry, M., Sayers, R., Cullen, R., Black, B., … Leung, W., … Weatherall, M., Beasley, R. W., on behalf of the INFORM ASTHMA collaborators, including Kerse, K., Lynch, F., Sika-Paotonu, D., & Semprini, R. (2026). Budesonide-formoterol versus terbutaline reliever in adults with asthma using maintenance inhaled corticosteroids in New Zealand (INFORM ASTHMA): An open-label, parallel group, randomised, controlled, phase 4 trial. Lancet Respiratory Medicine. Advance online publication. doi: 10.1016/S2213-2600(25)00327-3 Journal - Research Article

Leung, W., Reddel, H. K., Hung, T., Weatherall, M., Pelzer, I., Holliday, M., Sullivan, T., … Baker, M. G., … Beasley, R., & Hancox, R. J. (2026). Cost-effectiveness of as-needed budesonide-formoterol in adults with mild asthma: The Novel START trial. ERJ Open Research, 12(1), 00949-2025. doi: 10.1183/23120541.00949-2025 Journal - Research Article

Gordon, L. G., Leung, W., Johns, R., McNoe, B., Lindsay, D., Merollini, K. M. D., … Whiteman, D. C. (2022). Estimated healthcare costs of melanoma and keratinocyte skin cancers in Australia and Aotearoa New Zealand in 2021. International Journal of Environmental Research & Public Health, 19, 3178. doi: 10.3390/ijerph19063178 Journal - Research Article

Leung, W., Kvizhinadze, G., Nair, N., & Blakely, T. (2016). Adjuvant trastuzumab in HER2-positive early breast cancer by age and hormone receptor status: A cost-utility analysis. PLoS Medicine, 13(8), e1002067. doi: 10.1371/journal.pmed.1002067 Journal - Research Article

Bolland, M. J., Leung, W., Tai, V., Bastin, S., Gamble, G. D., Grey, A., & Reid, I. R. (2015). Calcium intake and risk of fracture: Systematic review. BMJ, 351, h4580. doi: 10.1136/bmj.h4580 Journal - Research Article

Back to top